14 Months After U.S. FDA Charged India's Lupin, Manufacturing Facility At Mandideep Cleared

MUMBAI - A long trail of hair splitting audits and investigations came to an end for India's drug maker Lupin as U.S. FDA issued an "All Clear" statement for the company's Mandideep manufacturing site in the central Indian state of Madhya Pradesh